Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach

Hester Lieng; Padraig Warde; Philippe Bedard; Robert J Hamilton; Aaron R Hansen; Michael A S Jewett; Martin O'malley; Joan Sweet; Peter Chung

doi:10.5489/cuaj.4531

Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach

Can Urol Assoc J. 2018 Feb;12(2):59-66. doi: 10.5489/cuaj.4531. Epub 2017 Dec 1.

Authors

Hester Lieng¹, Padraig Warde¹, Philippe Bedard², Robert J Hamilton³, Aaron R Hansen², Michael A S Jewett³, Martin O'malley⁴, Joan Sweet⁵, Peter Chung¹

Affiliations

¹ Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network and Department of Radiation Oncology, University of Toronto; Toronto, ON, Canada.
² Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network and Department of Medicine, University of Toronto; Toronto, ON, Canada.
³ Department of Surgery (Urology) and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto; Toronto, ON, Canada.
⁴ Division of Abdominal Imaging, Joint Department of Medical Imaging, University of Toronto; Toronto, ON, Canada.
⁵ Department of Pathology and Lab Medicine, University Health Network, University of Toronto; Toronto, ON, Canada.

Abstract

Testicular seminoma most commonly affects young men and is associated with favourable prognosis. Various followup schedules and imaging protocols for testicular seminoma have been described without overall consensus. We reviewed the literature together with our experience at the Princess Margaret Cancer Centre and present an evidence-based followup approach for patients with stage I and II seminoma.

Publication types

Review